Mirae Asset Securities USA Inc. Buys 300,000 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mirae Asset Securities USA Inc. raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 50.0% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 900,000 shares of the exchange traded fund’s stock after purchasing an additional 300,000 shares during the quarter. SPDR S&P Biotech ETF comprises 3.6% of Mirae Asset Securities USA Inc.’s portfolio, making the stock its 5th largest position. Mirae Asset Securities USA Inc.’s holdings in SPDR S&P Biotech ETF were worth $88,920,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the stock. Avantax Advisory Services Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 17.2% in the 1st quarter. Avantax Advisory Services Inc. now owns 9,619 shares of the exchange traded fund’s stock worth $913,000 after purchasing an additional 1,415 shares during the period. Kingsview Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 3.8% in the first quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock valued at $332,000 after buying an additional 127 shares during the period. Edgestream Partners L.P. acquired a new position in SPDR S&P Biotech ETF during the first quarter valued at approximately $336,000. Resurgent Financial Advisors LLC grew its stake in SPDR S&P Biotech ETF by 47.1% during the first quarter. Resurgent Financial Advisors LLC now owns 4,632 shares of the exchange traded fund’s stock worth $439,000 after buying an additional 1,483 shares during the period. Finally, Bessemer Group Inc. grew its stake in SPDR S&P Biotech ETF by 1.7% during the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock worth $87,572,000 after buying an additional 15,794 shares during the period.

SPDR S&P Biotech ETF Trading Down 5.3 %

Shares of XBI stock opened at $91.83 on Friday. The company has a market cap of $7.00 billion, a PE ratio of 11.47 and a beta of 1.11. The company’s fifty day simple moving average is $98.95 and its 200-day simple moving average is $96.03. SPDR S&P Biotech ETF has a 52 week low of $69.32 and a 52 week high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.